• Table of Contents

    May 7, 2026, 10:05

  • Improving Access to Nuclear Medicine in Island Regions: A Cost-Minimization Analysis of Radiopharmaceutical Supply Strategies

    May 1, 2026, 00:00

  • Evaluating the Performance of Claude 3.7 Sonnet in Data Extraction Automation for Systematic Literature Reviews

    May 1, 2026, 00:00

  • Cost-Effectiveness of Resmetirom for Metabolic Dysfunction-Associated Steatohepatitis in Brazil

    May 1, 2026, 00:00

  • Economic Evaluation and Budget Impact of Biosimilar Trastuzumab for HER2-Positive Metastatic Breast Cancer in Thailand: Policy Implications for Access and Affordability

    May 1, 2026, 00:00

  • Cost-Effectiveness of Vascular Endothelial Growth Factor Inhibitors in the Management of Wet Age-Related Macular Degeneration: A Systematic Review

    May 1, 2026, 00:00

  • Patient Preferences for Radiology Appointments and Factors Influencing Attendance Adherence: A Discrete Choice Experiment in Singapore Based on Behavioral Economics

    May 1, 2026, 00:00

  • Psychometric Performance of EQ-HWB and EQ-HWB-9 Self-Complete and Interviewer-Administered Versions in Literate, Low-Literacy, and Patient Populations in Indonesia

    May 1, 2026, 00:00

  • Custo-Efetividade da Teriparatida em Homens com Osteoporose Grave no Brasil

    May 1, 2026, 00:00

  • Economic Impact of Self-Injected Biologics for Rheumatoid Arthritis in Japan: A Propensity Score-Matched Analysis From a Public Healthcare Payer Perspective

    May 1, 2026, 00:00

  • Editorial Board

    May 1, 2026, 00:00

  • Assessing the Impact of a Social Program Using EQ-HWB-9 and EQ-5D-5L: The Dara Project

    May 1, 2026, 00:00

  • Long-Term Changes in Health-Related Quality of Life and Economic Burden After a SARS-CoV-2 Infection: Analysis of the Long COVID Prospective Cohort Study in Nairobi

    May 1, 2026, 00:00

  • Cost-Utility Analysis of Add-On Vericiguat to Standard Treatment in Thai Patients With Heart Failure and Reduced Ejection Fraction

    May 1, 2026, 00:00

  • Incremental Direct Cost of Chronic Obstructive Pulmonary Disease in Colombia Using Doubly Robust Methods on Administrative Data

    May 1, 2026, 00:00

  • Comparative Assessment of Short Form 6-Dimension Health State Preferences Among Lebanese Population Pre- and Post-COVID-19 Pandemic

    May 1, 2026, 00:00

  • Team Learning in Head and Neck Surgery: An Economic and Quality Management Perspective

    Mar 1, 2026, 00:00

  • Table of Contents

    Mar 1, 2026, 00:00

  • Scaling-Up Nutrition: A Benefit-Cost and Cost-Effectiveness Analysis of Increasing Coverage of Nutrition Interventions in the Republic of Yemen

    Mar 1, 2026, 00:00

  • Economic Burden of Ischemic Heart Disease in Morocco: Evidence From a Teaching Hospital, a Cost-of-Illness Study

    Mar 1, 2026, 00:00

  • A Randomized Online Grocery Store Trial to Test a Salient Tiered Food and Beverage Tax in Saudi Arabia

    Mar 1, 2026, 00:00

  • Current Generics Utilization and Associated Savings in Saudi Arabia: Insights From a Private Claims Database

    Mar 1, 2026, 00:00

  • Cost Comparison of 2 Different Targets for Glycemic Control in Women With Gestational Diabetes: Evaluation From the TARGET Stepped-Wedge Randomized Trial

    Mar 1, 2026, 00:00

  • The Economic Burden of Foodborne Diseases in Singapore

    Mar 1, 2026, 00:00

  • Editorial Board

    Mar 1, 2026, 00:00

  • Economic Burden and Cost-Effectiveness of Cancer Care in Ethiopia: A Systematic Review

    Mar 1, 2026, 00:00

  • Real-World Data on Cervical Cancer: The Impact of 2020 COVID-19 Outbreak on the Treatment Patterns and Healthcare Resources Utilization in Brazilian Public Health System

    Mar 1, 2026, 00:00

  • Navigating the Transition to Value-Based Healthcare in Saudi Arabia: A Qualitative Study of Policy-Maker Perspectives

    Mar 1, 2026, 00:00

  • Expanding the Utility of Vision-Specific Instruments in Thai Health Economic Evaluation: Reflections on Mapping Impact of Vision Impairment Questionnaire to EQ-5D-5L

    Mar 1, 2026, 00:00

  • The Impact of Care Burden of Young Carers on Their Preference for Social Supports

    Mar 1, 2026, 00:00

  • The Association Between Patient-Reported Experience Measures and Patient-Reported Outcome Measures Among Patients With Diabetes in the Kingdom of Saudi Arabia

    Mar 1, 2026, 00:00

  • Mapping the Children’s Dermatology Life Quality Index Questionnaire to EQ-5D-Y-3L in Pediatric Patients With Atopic Dermatitis

    Mar 1, 2026, 00:00

  • Analysis of Mortality Trajectory Patterns in the Middle East and North Africa: Which Diseases Are the Deadliest?

    Mar 1, 2026, 00:00

  • RWD303 The Impact of Care Burden of Young Carers on Their Preference for Social Supports

    Mar 1, 2026, 00:00

  • The Economic Burden of Maternal Death in Jordan From 2018 to 2021: Social and Geographic Variations

    Mar 1, 2026, 00:00

  • Toward Value-Based Healthcare in the Arabian Gulf and Wider Regions: New Evidence and Future Directions

    Mar 1, 2026, 00:00

  • Exploring the Dual Dimensions: Economic Burden and Social Support Among Patients With Schizophrenia in Saudi Arabia

    Mar 1, 2026, 00:00

  • Adapting a Benefit Trade-Off Instrument to Measure Health Inequality Aversion in the United States

    Jan 1, 2026, 00:00

  • Author Reply

    Jan 1, 2026, 00:00

  • Table of Contents

    Jan 1, 2026, 00:00

  • Cost-Analysis of Adherence to Antimicrobial Guidelines as Part of Antimicrobial Stewardship Strategies in 6 Latin American Countries: A Pilot Experience Focusing on Economic Impact

    Jan 1, 2026, 00:00

  • Person-Centered Intervention for People Living With HIV in the Philippines: A Cost-Effective Approach for Resource Allocation Decisions

    Jan 1, 2026, 00:00

  • Disparities in Out-of-Pocket Expenditures Among Hospitalized Patients With COVID-19 in Iran: A Decomposition Analysis of Inequality

    Jan 1, 2026, 00:00

  • Translation and Testing Psychometric Properties of the Thai Version of Vision Bolt-On EQ-5D in Patients With Visual Impairment

    Jan 1, 2026, 00:00

  • Public Preferences for Reducing Health Inequality in Japan: A National Survey

    Jan 1, 2026, 00:00

  • Latin American and Caribbean Trends and Health Priorities in Cost-Effectiveness Studies: A Bibliometric Analysis in Scopus in the 21st Century

    Jan 1, 2026, 00:00

  • Cost-Effectiveness of Text Messaging to Reengage Culturally and Linguistically Diverse Communities to Breast Cancer Screening: A Modeling Study

    Jan 1, 2026, 00:00

  • Prevention of Heart Failure With Icosapent Ethyl Results in Cost-Savings in the Spanish Population With Established Cardiovascular Disease

    Jan 1, 2026, 00:00

  • Learning From Local Contexts: Practical Pathways Toward Health Equity

    Jan 1, 2026, 00:00

  • Reducing the Travel Burden for Patients to Access Specialized Medicines in Paraná, Brazil

    Jan 1, 2026, 00:00

  • Valuation of EQ-5D Health States for Adults in Low-, Lower-Middle, and Upper-Middle-Income Countries: A Systematic Review

    Jan 1, 2026, 00:00

  • Averting Cancer: The Economic Case for Expanding HPV Vaccination

    Jan 1, 2026, 00:00

  • From Model to Clinic: Practical Considerations for Applying the Chinese Diabetes Risk Score in Prediabetes Screening

    Jan 1, 2026, 00:00

  • A Framework for Patient Prioritization in Bariatric Surgery Using a Predictive Success Score Versus a First-In First-Out Approach: A Cost-Effectiveness Analysis

    Jan 1, 2026, 00:00

  • Editorial Board

    Jan 1, 2026, 00:00

  • Real-World Effectiveness and Cost-Utility Analysis of Second-Line Immunotherapy for Non-Oncogene-Addicted Advanced Non-Small Cell Lung Cancer

    Jan 1, 2026, 00:00

  • Evaluating the Factor Structure of the Preliminary Version of EuroQol Health and Well-Being Instrument in China: A Replication of the Confirmatory Factor Analysis

    Jan 1, 2026, 00:00

  • What Role Does Equity Play in Australia’s Health Technology Assessment Processes? A Review of the Pharmaceutical Benefits Advisory Committee Recommendations Regarding Vaccines

    Jan 1, 2026, 00:00

  • Editorial Board

    Nov 5, 2025, 08:27

  • Cost-Effectiveness Analysis Comparing Ceftazidime/Avibactam With Standard of Care in the Treatment of Hospital and Ventilator-Acquired Pneumonia in the Philippines

    Nov 1, 2025, 00:00

  • Psychometric Validation of EQ-5D-5L in Individuals With Chronic Spinal Cord Injury in China

    Nov 1, 2025, 00:00

  • Cost Analysis of Diabetes Mellitus Treatment in the Public Sector in Dubai, The United Arab Emirates: Analysis Based on a Global Perspective Model

    Nov 1, 2025, 00:00

  • Medicines Policy in Action: The Impact on Volume and Cost of Biologic Medicines After Biosimilar Introduction

    Nov 1, 2025, 00:00

  • Table of Contents

    Nov 1, 2025, 00:00

  • Predicting the EQ-5D-5L Utility Scores From the Impact of Vision Impairment Questionnaire in Thai Patients

    Nov 1, 2025, 00:00

  • Correction

    Nov 1, 2025, 00:00

  • Cost and Budget Impact of Layering Depression Care Onto Existing HIV and Noncommunicable Disease Care Services in Western Kenya

    Nov 1, 2025, 00:00

  • Healthcare Costs and Main Characteristics of Childbirth and Neonatal Inpatient Care From the Brazilian Public Health System Perspective

    Nov 1, 2025, 00:00

  • Valuation of the Alzheimer’s Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in Chile

    Nov 1, 2025, 00:00

  • Disseminated Histoplasmosis in People Living With HIV: What Are the Care Costs for Brazil?

    Nov 1, 2025, 00:00

  • Comparison of Cancer Registry Data Between Sweden and China and the Impact on Real-World Health Research

    Nov 1, 2025, 00:00

  • Cost-Utility Analysis of Expanding Human Papillomavirus Vaccination to Adult Women in Indonesia: A Markov Model Approach

    Nov 1, 2025, 00:00

  • Epidemiology, Real-World Treatment, and Economic Burden of Waldenström Macroglobulinemia: A Comprehensive Analysis Based on Anonymized Claims Data Between 2010 and 2022

    Nov 1, 2025, 00:00

  • Self-Reported Health-Related Quality of Life in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions

    Nov 1, 2025, 00:00

  • Impact of Severe Hemophilia on Costs and Quality of Life in South American Men: Findings From the CHESS LATAM Study

    Nov 1, 2025, 00:00

  • Disclaimer

    Oct 23, 2025, 09:07

  • RWD204 COMPARATIVE OUTCOMES OF INDWELLING PERITONEAL CATHETERS (IPCS) VERSUS LARGE VOLUME PARACENTESIS (LVP) IN THE MANAGEMENT OF MALIGNANT AND NON-MALIGNANT ASCITES: A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • Peer Reviewers

    Oct 1, 2025, 00:00

  • RWD162 DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR THE RISK OF SARCOPENIA IN PATIENTS WITH COPD

    Oct 1, 2025, 00:00

  • RWD24 ACCEPTANCE OF REAL-WORLD EVIDENCE IN HTA IN JAPAN: IS THE POTENTIAL BEING REALIZED?

    Oct 1, 2025, 00:00

  • RWD131 COST-EFFECTIVENESS OF DOSTARLIMAB PLUS CHEMOTHERAPY FOR PRIMARY ADVANCED OR RECURRENT ENDOMETRIAL CANCER FROM TAIWAN’S NATIONAL HEALTH INSURANCE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD298 PUBLIC HEALTH IMPACT ASSESSMENT OF RSVPREF3 OA ADJUVANTED VACCINE ON RESPIRATORY SYNCYTIA VIRUS IN TAIWAN, HONG KONG, AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD72 EVALUATING THE OPTIMAL AGE FOR NATIONAL GASTRIC CANCER SCREENING IN KOREA: A REAL-WORLD, POPULATION-BASED COHORT

    Oct 1, 2025, 00:00

  • RWD225 COST-EFFECTIVENESS OF DOCETAXEL VERSUS IMMUNE CHECKPOINT INHIBITORS AS TREATMENT FOR ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER: A TARGETED LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD153 ECONOMIC EVALUATIONS OF ORPHAN DRUGS FOR RARE KIDNEY DISEASES IN LOW AND MIDDLE INCOME COUNTRIES: A SYSTEMATIC REVIEW AND BIBLIOMETRIC ANALYSIS

    Oct 1, 2025, 00:00

  • RWD38 PRESCRIPTION PATTERN AND COSTS OF ANTIDIABETIC MEDICATIONS IN PATIENTS WITH TYPE 2 DIABETES BY SPECIALIST PHYSICIANS AND NON-SPECIALIST PHYSICIANS

    Oct 1, 2025, 00:00

  • RWD182 QUANTIFYING THE VALUE OF KNOWING: MEASURING PATIENT COMMUNITY PREFERENCES FOR GENOMIC TESTING IN RARE DISEASES

    Oct 1, 2025, 00:00

  • RWD292 PREFERENCE FOR VIRTUAL REALITY EXERGAME IN WEIGHT CONTROL SETTING AMONG YOUNG ADULTS: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD195 ESTIMATING THE AVERAGE TREATMENT EFFECT AMONG PATIENTS WITH HEART FAILURE USING TARGETED MAXIMUM LIKELIHOOD ESTIMATION: IMPLICATIONS FROM A LARGE-SCALE HEALTH ADMINISTRATIVE DATABASE

    Oct 1, 2025, 00:00

  • RWD285 COST-UTILITY ANALYSIS OF ECULIZUMAB FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) IN THAILAND

    Oct 1, 2025, 00:00

  • RWD159 PREFERENCES AND WILLINGNESS TO PAY FOR MAINTENANCE INHALERS AMONG ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THAILAND: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD280 THE LONG-TERM EFFECTS OF OPIOID USE BEFORE TOTAL JOINT REPLACEMENT SURGERY: A DOSE-RESPONSE TRIAL EMULATION USING NEW ZEALAND LINKED ADMINISTRATIVE DATA

    Oct 1, 2025, 00:00

  • RWD34 GENERATING REAL-WORLD UTILITY VALUES FOR PEDIATRIC HEALTH STATES IN TAIWAN: A NATIONWIDE EQ-5D-Y-3L VALUATION STUDY USING COMPOSITE TIME TRADE-OFF

    Oct 1, 2025, 00:00

  • RWD186 A QUALITATIVE STUDY ON OBESE ADULTS’ PERCEPTIONS OF USING ARTIFICIAL INTELLIGENCE FOR WEIGHT MANAGEMENT COUNSELING

    Oct 1, 2025, 00:00

  • RWD228 ASSOCIATION BETWEEN ANTICHOLINERGIC BURDEN AND THE RISK OF CARDIOVASCULAR EVENTS IN OLDER ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD142 ANALYSIS OF IMPLEMENTATION AND TERMINATION CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS FOR NEW DRUGS UNDER TAIWAN’S NATIONAL HEALTH INSURANCE SYSTEM

    Oct 1, 2025, 00:00

  • RWD197 COST-EFFECTIVENESS OF PRIMARY AND COMMUNITY CARE PROGRAMMES FOR OSTEOARTHRITIS: A MODELING STUDY USING DATA FROM A MULTI-CENTER NATIONAL PILOT PROGRAM

    Oct 1, 2025, 00:00

  • RWD161 COMPARISON OF RISK PREDICTION MODELS FOR KIDNEY DISEASE: AN EXTERNAL VALIDATION USING 0.5 MILLION UK BIOBANK PARTICIPANTS

    Oct 1, 2025, 00:00

  • RWD205 COST-EFFECTIVENESS OF CONCURRENT KOREAN AND WESTERN MEDICINE TREATMENT VS. USUAL CARE FOR CAR ACCIDENT-RELATED WHIPLASH INJURIES IN KOREA: A MARKOV MODEL DECISION ANALYSIS

    Oct 1, 2025, 00:00

  • RWD171 RESEARCH ON STAKEHOLDER COLLABORATION MECHANISM FOR MEDICAL DATA SHARING: A THREE-PARTY EVOLUTIONARY GAME ANALYSIS

    Oct 1, 2025, 00:00

  • RWD320 COST-EFFECTIVENESS OF RIBOCICLIB PLUS LETROZOLE FOR PREMENOPAUSAL WOMEN WITH HR+/HER2- ADVANCED BREAST CANCER IN THAILAND: A SOCIETAL PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD185 CAREGIVERS’ ACCEPTANCE AND PERSPECTIVES ON AN AUGMENTED REALITY-BASED PRESSURE ULCER ASSESSMENT DEVICE: A QUALITATIVE STUDY BASED ON THE TECHNOLOGY ACCEPTANCE MODEL

    Oct 1, 2025, 00:00

  • RWD41 REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF FIRST-LINE THERAPIES OF HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD274 ECONOMIC EVALUATION OF USING A UNIT DOSE DISPENSING ROBOT IN A THAI TERTIARY HOSPITAL

    Oct 1, 2025, 00:00

  • RWD104 EVALUATING FERTILITY TREATMENT COSTS IN JAPAN: A MICRO-COSTING ANALYSIS

    Oct 1, 2025, 00:00

  • RWD184 FNEURONET: A SEX-SPECIFIC DEEP LEARNING FRAMEWORK FOR AUTISM SPECTRUM DISORDER (ASD) AND ATTENTION DEFICIT AND HYPERACTIVITY DISORDER (ADHD) CLASSIFICATION IN FEMALE COHORTS BASED ON RESTING-STATE FMRI IMAGES

    Oct 1, 2025, 00:00

  • RWD128 INCORPORATING REAL-WORLD DATA AND MATHEMATICAL MODELING TO ESTIMATE THE UNDIAGNOSED CHRONIC HEPATITIS B POPULATION

    Oct 1, 2025, 00:00

  • RWD192 IMPLEMENTATION OF OSTEOPOROSIS SCREENING IN HONG KONG: PERSPECTIVES OF HEALTHCARE PROVIDERS THROUGH THE LENS OF THE CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH

    Oct 1, 2025, 00:00

  • RWD260 A COMPARATIVE ANALYSIS OF THE REDAPT SYSTEM IN REVISION TOTAL HIP ARTHROPLASTY: EVIDENCE FROM A LARGE US CLAIMS DATABASE

    Oct 1, 2025, 00:00

  • RWD18 ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE AND ITS INFLUENCING FACTORS IN CHINESE PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY

    Oct 1, 2025, 00:00

  • RWD281 LEVERAGING NATIONWIDE HEALTH AND INSURANCE RECORDS TO TRACK BIOLOGIC DRUG DIFFUSION IN IBD: A 20-YEAR REAL-WORLD STUDY FROM ISRAEL

    Oct 1, 2025, 00:00

  • RWD82 LEVERAGING REAL-WORLD DATA (RWD) TO INFORM DRUG REIMBURSEMENT IN ASIA-PACIFIC: ADDRESSING CHALLENGES AND BUILDING SOLUTIONS

    Oct 1, 2025, 00:00

  • RWD146 ASSOCIATION BETWEEN FRAILTY STATUS AND GLYCEMIC CONTROL IN MIDDLE-AGED AND OLDER ADULTS WITH TYPE 2 DIABETES: A CROSS-SECTIONAL ANALYSIS OF THE UK BIOBANK COHORT

    Oct 1, 2025, 00:00

  • RWD268 IMPACT OF MEDICAL INSURANCE PRICE NEGOTIATION POLICY ON INNOVATION OF CHINESE LISTED PHARMACEUTICAL COMPANIES: DIFFERENCE-IN-DIFFERENCES ANALYSIS

    Oct 1, 2025, 00:00

  • RWD126 UNDERSTANDING REAL-WORLD CLINICAL AND ECONOMIC BURDEN OF DIFFERENT DEVICES STRATEGIES FOR THE ENDOVASCULAR TREATMENT OF SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN JAPAN: A REAL-WORLD CLAIMS DATA ANALYSIS PROTOCOL

    Oct 1, 2025, 00:00

  • RWD22 MINDFULNESS-BASED INTERVENTIONS FOR PSYCHOLOGICAL DISTRESS IN LUNG CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD201 INCIDENCE, RISK FACTORS, AND TEMPORAL TRENDS OF TONGUE CANCER: A POPULATION-BASED STUDY

    Oct 1, 2025, 00:00

  • RWD62 TREATMENT PATTERNS FOR CHEMOTHERAPY-INDUCED ANEMIA IN CHINESE POPULATION: A MULTI-CENTER RETROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD149 ECONOMIC IMPLICATIONS OF GENERIC POMALIDOMIDE ADOPTION IN THE MANAGEMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: A BUDGET IMPACT ANALYSIS AT THE JALISCO INSTITUTE OF CANCEROLOGY

    Oct 1, 2025, 00:00

  • RWD85 PRICE VARIATIONS AMONG STANDARDIZED VOLUNTARY HEALTH INSURANCE PLANS: EVIDENCE FROM HONG KONG

    Oct 1, 2025, 00:00

  • RWD108 COST AND COST-EFFECTIVENESS OF ROBOT-ASSISTED SURGERY (RAS) IN KOREA: AN ECONOMIC REVIEW OF RAS BETWEEN 2007 AND 2025

    Oct 1, 2025, 00:00

  • Research Presentations Financial Disclosure Statements

    Oct 1, 2025, 00:00

  • RWD282 REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS IN JAPAN: A RETROSPECTIVE CLAIMS ANALYSIS

    Oct 1, 2025, 00:00

  • RWD242 PROPOSAL OF USING CLAIMS-BASED DIAGNOSES AND PRENATAL EXAMINATIONS TO IDENTIFY PREGNANCY IN TAIWAN: NATIONAL HEALTH INSURANCE RESEARCH DATABASE

    Oct 1, 2025, 00:00

  • RWD322 MENTAL HEALTH AS MEDIATOR LINKING AGE-FRIENDLY COMMUNITIES TO CARDIOVASCULAR MULTIMORBIDITY: EVIDENCE FROM A LARGE NATIONAL COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD42 ECONOMIC EVALUATION OF NEOADJUVANT-ADJUVANT VERSUS ADJUVANT-ONLY PEMBROLIZUMAB IN RESECTABLE MELANOMA

    Oct 1, 2025, 00:00

  • RWD308 DOES IMPROVED HOSPITAL MANAGEMENT ENHANCE HEALTHCARE EFFICIENCY? EVIDENCE FROM COUNTY-LEVEL HOSPITALS IN CHINA

    Oct 1, 2025, 00:00

  • RWD10 PREFERENCES FOR ADOPTING ARTIFICIAL INTELLIGENCE IN RADIATION THERAPY TREATMENT: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD141 USING SCALING FACTOR MODEL TO ESTIMATE THE VALUE SET OF PSORIASIS BOLT-ON EQ-5D-5L HEALTH STATES

    Oct 1, 2025, 00:00

  • RWD51 CONSENSUS-BASED GUIDANCE FOR BONE HEALTH OPTIMIZATION IN SPINE SURGERY

    Oct 1, 2025, 00:00

  • RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023

    Oct 1, 2025, 00:00

  • RWD317 THE BURDEN OF JAPANESE ENCEPHALITIS IN THE ASIA-PACIFIC: INSIGHTS FROM REAL-WORLD DATA

    Oct 1, 2025, 00:00

  • RWD58 RE-ESTIMATING AN EQ-5D-5L VALUE SET FOR CHINA

    Oct 1, 2025, 00:00

  • RWD246 CONSUMER PREFERENCES FOR ATTRIBUTES AMONG VOLUNTARY HEALTH INSURANCE PLANS: A SYSTEMATIC REVIEW

    Oct 1, 2025, 00:00

  • RWD99 ASSESSING THE SOCIOECONOMIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY ON CARER’S LIFE IN AUSTRALIA: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD14 ASSESSMENT OF STROKE PATTERNS AND RISK FACTORS IN NORTHEAST INDIA: A HOSPITAL-BASED PROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD39 PREDICTING SURVIVAL IN MULTIPLE MYELOMA PATIENTS WITH DIABETES USING MACHINE LEARNING: A 20-YEAR COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD61 CHARACTERISING THE LATENCY PERIOD OF SECONDARY PRIMARY MALIGNANCY AND LYMPHOMA ONSET FOLLOWING TISAGENLECLEUCEL (CAR-T CELL THERAPY): A REAL-WORLD DATA ANALYSIS

    Oct 1, 2025, 00:00

  • RWD231 IMPACT OF CHILD MALTREATMENT ON THE COSTS OF HEALTH SERVICE USE AND PRODUCTIVITY LOSS: FINDINGS FROM THE AUSTRALIAN CHILD MALTREATMENT STUDY

    Oct 1, 2025, 00:00

  • RWD124 IDENTIFYING RISK-FACTORS ASSOCIATED WITH POSTPARTUM DEPRESSION THROUGH CLAIMS DATA IN JAPAN

    Oct 1, 2025, 00:00

  • RWD45 OUT OF POCKET COSTS AND AFFORDABILITY OF AUSTRALIAN EATING DISORDER MEDICARE BENEFITS SCHEME SERVICES USING LINKED DATA

    Oct 1, 2025, 00:00

  • RWD254 BENEFIT OF IMMEDIATE INITIATION OF NIRMATRELVIR/RITONAVIR AGAINST LONG COVID: REAL-WORLD COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD73 THE SOCIO-ECONOMIC BURDEN OF END-STAGE KIDNEY DISEASE: REAL-WORLD EVIDENCE FROM BULGARIA

    Oct 1, 2025, 00:00

  • RWD76 POTENTIAL RISK OF ACUTE PANCREATITIS WITH GLP-1 RECEPTOR AGONISTS

    Oct 1, 2025, 00:00

  • RWD311 EXPLORING THE EVALUATION OF NETWORK META-ANALYSIS ASSUMPTIONS: CURRENT APPROACHES AND PRACTICES

    Oct 1, 2025, 00:00

  • RWD116 DISPARITIES IN HEALTH OUTCOMES AND CARE AMONG ALK-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS: REAL-WORLD EVIDENCE OF SOCIAL DETERMINANTS OF HEALTH

    Oct 1, 2025, 00:00

  • RWD78 BURDEN OF INTRAVENOUS IMMUNOGLOBULIN USE AMONG ADULTS WITH GENERALIZED MYASTHENIA GRAVIS IN JAPAN

    Oct 1, 2025, 00:00

  • RWD307 EXPLORING LONG COVID IN TAIWANESE CHILDREN: IMMUNOLOGICAL INSIGHTS AND CLINICAL IMPACTS

    Oct 1, 2025, 00:00

  • RWD269 A MACHINE LEARNING-DRIVEN MULTIDIMENSIONAL EVALUATION OF TANDOSPIRONE FORMULATIONS BASED ON REAL-WORLD EVIDENCE

    Oct 1, 2025, 00:00

  • RWD96 ESTIMATING HEALTHCARE COSTS ASSOCIATED WITH ISCHEMIC HEART DISEASE AND STROKE USING SEVERAL DIFFERENT STATISTICAL MODELS

    Oct 1, 2025, 00:00

  • RWD321 COST-EFFECTIVENESS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL IN ELDERLY PATIENTS WITH SEVERE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Oct 1, 2025, 00:00

  • RWD87 ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE MEDICATIONS BASED ON REAL-WORLD DATA

    Oct 1, 2025, 00:00

  • RWD203 INEQUALITY AND DETERMINANTS OF ACCESS TO ESSENTIAL ANTICANCER MEDICINES FOR CHILDREN IN CHINA

    Oct 1, 2025, 00:00

  • RWD258 ONE METHOD OF BREAKING DOWN MEDICAL EXPENSES BY ILLNESS: ESTIMATING MARGINAL AND AVERAGE BURDEN

    Oct 1, 2025, 00:00

  • RWD288 REHABILITATION FOR PATIENTS WITH CANCER: SURVIVAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION BASED ON MULTICENTER CANCER REGISTRY AND ADMINISTRATIVE DATA IN JAPANESE REAL-WORLD SETTINGS

    Oct 1, 2025, 00:00

  • RWD115 COST-EFFECTIVENESS OF BUPROPION FOR SELF-CARE ADHERENCE AND GLYCAEMIC CONTROL IN MULTIMORBID TYPE 2 DIABETES MELLITUS AND MILD DEPRESSION [ADHERE-DM] – A CROSS-OVER RANDOMIZED CONTROLLED TRIAL-BASED ECONOMIC EVALUATION

    Oct 1, 2025, 00:00

  • RWD248 DRUG SURVIVAL, SWITCHING PATTERN, AND COSTS OF MODERATE TO SEVERE PSORIASIS PATIENTS TREATED WITH BIOLOGICS IN CHINA

    Oct 1, 2025, 00:00

  • RWD207 COMPARISON AND POLICY IMPLICATIONS OF AMBULANCE DURATION AND ASSOCIATED COSTS FOR SUICIDAL PRESENTATIONS VERSUS GENERAL PRESENTATIONS IN AUSTRALIA

    Oct 1, 2025, 00:00

  • RWD227 DAILY DOSES AND DURATION OF GABAPENTIN AND PREGABALIN USE FOR PAIN MANAGEMENT AMONG OPIOID USERS BELOW AND ABOVE 65 YEARS OLD: TRENDS AND PATTERNS

    Oct 1, 2025, 00:00

  • RWD118 DESIGNING A PHYSICIAN CAPACITY-BASED PAYMENT FRAMEWORK UNDER A GLOBAL BUDGET: INSIGHTS FROM PHYSICIAN-LEVEL CLAIMS DATA

    Oct 1, 2025, 00:00

  • RWD302 UTILIZATION OF PATIENT-EXPERIENCED DATA IN HEALTH TECHNOLOGY ASSESSMENTS IN ASIA PACIFIC REGION

    Oct 1, 2025, 00:00

  • RWD5 UNLOCKING THE STRATEGIC POTENTIAL OF REAL-WORLD EVIDENCE IN THE ASIA – PACIFIC PHARMACEUTICAL MARKET: EXECUTIVE INSIGHTS AND COMMERCIAL IMPLICATIONS

    Oct 1, 2025, 00:00

  • RWD65 BALANCING INNOVATION AND AFFORDABILITY: HEALTH SYSTEM TRADE-OFFS IN THAILAND’S REIMBURSEMENT RESTRICTION POLICIES FOR HIGH-COST MEDICINES

    Oct 1, 2025, 00:00

  • RWD86 PRELIMINARY REPORT OF SYSTEM DYNAMICS MODELING OF A CO-PAYMENT MECHANISM FOR BREAST CANCER PATIENTS IN MALAYSIA

    Oct 1, 2025, 00:00

  • RWD84 PATIENT VOICES IN HEALTH TECHNOLOGY ASSESSMENTS: INSIGHTS FROM AUSTRALIA AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD244 BODY WEIGHT-ASSOCIATED DIFFERENCES IN ADVERSE DRUG REACTION PROFILES OF AROMATASE INHIBITORS: A REAL-WORLD PHARMACOVIGILANCE STUDY USING FAERS DATABASE

    Oct 1, 2025, 00:00

  • RWD323 UNLOCKING PREFERENCES FOR WORK-LIFE BALANCE AND FERTILITY POLICIES AMONG WORKING WOMEN IN EAST ASIA: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD97 THE DIFFERENCE OF COST SAVINGS OF NATIONAL STANDARDIZED HEALTH TRAINING AMONG HEALTH INSURANCE SOCIETIES: A COHORT STUDY USING “WELLNESS-STAR?” HEALTH INSURANCE CLAIMS DATABASE

    Oct 1, 2025, 00:00

  • RWD140 REAL-WORLD UTILIZATION, PERSISTENCE, AND EFFECTIVENESS OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE ASTHMA: A MULTICENTER RETROSPECTIVE COHORT STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD31 ASSESSING ADOPTION AND FEASIBILITY OF THE HONG KONG REFERENCE FRAMEWORK FOR PREVENTIVE CARE IN OLDER ADULTS: A CROSS-SECTIONAL SURVEY OF PRIMARY CARE PRACTITIONERS

    Oct 1, 2025, 00:00

  • RWD208 COST-UTILITY AND BUDGET IMPACT ANALYSIS OF FARICIMAB FOR DIABETIC MACULAR EDEMA (DME) AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN INDONESIA

    Oct 1, 2025, 00:00

  • RWD135 TRENDS IN THE INCORPORATION OF CLINICAL OUTCOME ASSESSMENTS IN ASTHMA DRUG DEVELOPMENT IN JAPAN: A FIVE-YEAR REVIEW (2020-2024)

    Oct 1, 2025, 00:00

  • RWD257 HEALTH SAVINGS IMPACT OF MULTIVITAMIN SUPPLEMENTATION IN TAIWAN: A DEMENTIA RISK REDUCTION ECONOMIC MODEL

    Oct 1, 2025, 00:00

  • RWD226 MULTIDIMENSIONAL BURDEN OF NEUROFIBROMATOSIS TYPE 1 (NF1): A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD266 HEALTHCARE RESOURCE USE OF PEDIATRIC AND ADULT PATIENTS WITH SEIZURES ASSOCIATED WITH DRAVET SYNDROME, LENNOX-GASTAUT SYNDROME, OR TUBEROUS SCLEROSIS COMPLEX IN JAPAN

    Oct 1, 2025, 00:00

  • RWD134 EFFECT OF ALK-TKI IN ALK-REARRANGED VERSUS ALK-REARRANGED WITH PD-L1 POSITIVE NSCLC: A TARGET TRIAL EMULATION STUDY

    Oct 1, 2025, 00:00

  • RWD30 DETERMINANTS OF WILLINGNESS TO ACCEPT THE PNEUMOCOCCAL VACCINE: AN POPULATION-BASED STUDY IN HONG KONG

    Oct 1, 2025, 00:00

  • RWD319 AN EMPIRICAL STUDY ON THE DISCOUNTING RATE OF PHARMACOECONOMIC EVALUATIONS IN CHINA

    Oct 1, 2025, 00:00

  • RWD7 GLOBAL INCIDENCE, RISK FACTORS, AND TRENDS OF PHARYNGEAL CANCER BY ANATOMICAL SITES: A SYSTEMATIC ANALYSIS OF CANCER REGISTRIES

    Oct 1, 2025, 00:00

  • RWD111 UNPACKING THE MODULAR PAYMENT OF THE LEAD MATERNITY CARER SERVICE IN NEW ZEALAND: DEVELOPING INITIAL PROGRAM THEORY IN REALIST ECONOMIC EVALUATION

    Oct 1, 2025, 00:00

  • RWD40 EVALUATING THE REPRESENTATIVENESS OF A REAL-WORLD ONCOLOGY DATABASE DEVELOPED BY THE J-CONNECT CONSORTIUM: COMPARISON WITH JAPAN'S NATIONAL CANCER REGISTRY

    Oct 1, 2025, 00:00

  • RWD249 CRYOBALLOON VERSUS RADIOFREQUENCY ABLATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2025, 00:00

  • RWD1 FROM INFECTION TO RECOVERY: HEALTH-RELATED QUALITY OF LIFE TRAJECTORIES AMONG COVID-19 PATIENTS IN SELANGOR

    Oct 1, 2025, 00:00

  • RWD175 EVALUATING THE DISEASE SPECTRUM AND COST OF CARE AMONG NEUROLOGY INPATIENTS IN NORTHEAST INDIA: INSIGHTS FROM A REAL WORLD, HOSPITAL BASED STUDY

    Oct 1, 2025, 00:00

  • RWD283 COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB AND ATEZOLIZUMAB WITH CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR FIRST-LINE TREATMENT OF EXTENSIVE-STAGE SMALL-CELL LUNG CANCER IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD75 USING REAL WORLD DATA TO ESTIMATE THE COST OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) INFECTION IN A HIGH-RISK AUSTRALIAN POPULATION

    Oct 1, 2025, 00:00

  • RWD245 ARTIFICIAL INTELLIGENCE-POWERED IDENTIFICATION, ACCESS, AND UTILITY MAPPING OF REAL-WORLD DATA SOURCES FOR LUNG CANCER IN ASIA PACIFIC

    Oct 1, 2025, 00:00

  • RWD49 AN EQ-5D MULTILAYERED MEASURE OF HEALTH-RELATED QUALITY OF LIFE: IS THERE RELEVANCE AND NEED FOR IT?

    Oct 1, 2025, 00:00

  • RWD193 DEMOGRAPHIC AND LIFESTYLE DETERMINANTS OF SCREEN USE PATTERNS IN HONG KONG SECONDARY SCHOOL STUDENTS

    Oct 1, 2025, 00:00

  • RWD110 POLYPHARMACY AND RISK OF MAJOR CARDIOVASCULAR EVENTS AMONG CHINESE PATIENTS WITH DIABETES: A RETROSPECTIVE COHORT STUDY USING INSTRUMENTAL VARIABLE ANALYSIS

    Oct 1, 2025, 00:00

  • RWD301 EXPLORING DIAGNOSTIC PATHWAYS AND FACTORS FOR EARLY DETECTION OF LUNG CANCER IN SMALL AND LARGE NODULE PATIENTS

    Oct 1, 2025, 00:00

  • RWD199 A MOBILE-ACCESSIBLE COST-EFFECTIVE AI-AIDED SELF-ASSESSMENT TOOL FOR EARLY MEASLES DETECTION IN LOW-RESOURCE SETTINGS

    Oct 1, 2025, 00:00

  • RWD252 EVALUATING THE COST-EFFECTIVENESS OF TUMOR-TREATING FIELDS IN COMBINATION WITH TEMOZOLOMIDE FOR GLIOBLASTOMA IN SINGAPORE

    Oct 1, 2025, 00:00

  • RWD93 REAL-WORLD EFFECTIVENESS OF ATEZOLIZUMAB-BEVACIZUMAB, LENVATINIB AND SORAFENIB IN THE PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD107 CHARACTERISTICS AND ACCESSIBILITY OF ORPHAN DRUGS THROUGH 2017-2024 NATIONAL DRUG PRICE NEGOTIATION IN CHINA

    Oct 1, 2025, 00:00

  • RWD196 THE ROLE OF FOOD LABEL USE IN ENHANCING HEALTHCARE DECISION-MAKING AMONG PATIENTS WITH CHRONIC METABOLIC DISEASES

    Oct 1, 2025, 00:00

  • RWD151 COMPARATIVE ANALYSIS OF HTA GUIDELINES ON INDIRECT COSTS AND CAREGIVER UTILITIES: JAPAN VS. FOUR EUROPEAN COUNTRIES

    Oct 1, 2025, 00:00

  • RWD312 CHANGING ETIOLOGY OF CIRRHOSIS AND OTHER CHRONIC LIVER DISEASES: IMPLICATIONS FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE IN NON-CIRRHOTIC PATIENTS

    Oct 1, 2025, 00:00

  • RWD261 MYASTHENIA GRAVIS HEALTHCARE RESOURCE USE AND COST OF THERAPY IN AUSTRALIA

    Oct 1, 2025, 00:00

  • RWD6 COMPARATIVE ANALYSIS OF MEDICATION VALUE SETS ACROSS REFERENCE SOURCES TO ENSURE COMPLETE COVERAGE FOR REAL WORLD EVIDENCE STUDIES

    Oct 1, 2025, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »